Micro Emerging Active

Climb Bio's FDA Fast Track designation

New narrative with limited coverage — still forming.

Score
0.2
Velocity
▲ 0.0
Articles
3
Sources
1

Sentiment Timeline

Event Timeline

May 05, 2026
Climb Bio (CLYM) Enters Agreement for $110M Private Placement Financing Bullish
Apr 24, 2026
Arbutus Biopharma (ABUS) Wins FDA Fast Track for Imdusiran Bullish
Apr 22, 2026
FDA Fast Track and a BTIG Buy; Is Climb Bio (CLYM) a … Neutral

Related Articles

Climb Bio (CLYM) Enters Agreement for $110M Private Placement Financing

Yahoo Finance · May 05, 2026
Bearish

Arbutus Biopharma (ABUS) Wins FDA Fast Track for Imdusiran

Yahoo Finance · Apr 24, 2026
Mixed

Timeline

Last UpdatedApr 22, 2026